MorphoSys AG
XETRA:MOR
MorphoSys AG
Total Other Income
MorphoSys AG
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MorphoSys AG
XETRA:MOR
|
Total Other Income
-€52.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-53%
|
|
BioNTech SE
NASDAQ:BNTX
|
Total Other Income
-€2.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CureVac NV
NASDAQ:CVAC
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Total Other Income
-€2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Formycon AG
XETRA:FYB
|
Total Other Income
€96.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is MorphoSys AG's Total Other Income?
Total Other Income
-52.3m
EUR
Based on the financial report for Mar 31, 2024, MorphoSys AG's Total Other Income amounts to -52.3m EUR.
What is MorphoSys AG's Total Other Income growth rate?
Total Other Income CAGR 10Y
-53%
The average annual Total Other Income growth rates for MorphoSys AG have been 2% over the past three years , and -53% over the past ten years .